“Finishing the job of leprosy elimination requires renewed resolve and also a new way of approaching the challenge,” said Dr. Ann Aerts, Head of the Novartis Foundation for Sustainable Development.
A NIBR postdoctoral fellowship leads to the discovery of a key genetic mutation behind a form of blindness.
Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.
Sandoz, the generic division of Novartis, is working with a local partner in Brazil which is undertaking the first clinical trial in that country for a biosimilar drug.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.